Požymis
Arthritis
Inflammation of a joint.
Santrauka
- Taip pat vadinama
- Joint inflammation
- Kūno sistema
- Abnormality of the musculoskeletal system
Ši puslapis kaip duomenys
Norėdami perskaityti jį kaip JSON, pridėkite .json prie puslapio adreso arba nurodykite application/json.
library(jsonlite)
url <- "https://dantelabs.com/traits/arthritis.json"
page <- fromJSON(url)
page$trait$nameVienu tyrimu sužinokite genus, susijusius su Arthritis, ir kitą jūsų genomo dalį.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test173 genų susiję su Arthritis
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Arthritis. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ELF4E74 like ETS transcription factor 4 | Visada | 1 ligoje |
| IKZF2IKAROS family zinc finger 2 | Visada | 1 ligoje |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Visada | 1 ligoje |
| NLRP3NLR family pyrin domain containing 3 | Visada | 5 ligose |
| PDCD1programmed cell death 1 | Visada | 2 ligose |
| PLD4phospholipase D family member 4 | Visada | 1 ligoje |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Visada | 2 ligose |
| TBK1TANK binding kinase 1 | Visada | 1 ligoje |
| TRAF3TNF receptor associated factor 3 | Visada | 1 ligoje |
| ANKHANKH inorganic pyrophosphate transport regulator | Labai dažnai (80–99%) | 1 ligoje |
| ANKRD55ankyrin repeat domain 55 | Labai dažnai (80–99%) | 2 ligose |
| ASAH1N-acylsphingosine amidohydrolase 1 | Labai dažnai (80–99%) | 2 ligose |
| ATP7BATPase copper transporting beta | Labai dažnai (80–99%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Labai dažnai (80–99%) | 2 ligose |
| CCR1C-C motif chemokine receptor 1 | Labai dažnai (80–99%) | 1 ligoje |
| CD247CD247 molecule | Labai dažnai (80–99%) | 2 ligose |
| CD4CD4 molecule | Labai dažnai (80–99%) | 1 ligoje |
| CLCN7Cl-/H+ antiporter 7 | Labai dažnai (80–99%) | 1 ligoje |
| COPAcoat protein complex I subunit alpha | Labai dažnai (80–99%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| FASFas cell surface death receptor | Labai dažnai (80–99%) | 2 ligose |
| GLAgalactosidase alpha | Labai dažnai (80–99%) | 1 ligoje |
| HGDhomogentisate 1,2-dioxygenase | Labai dažnai (80–99%) | 2 ligose |
| HLA-Bmajor histocompatibility complex, class I, B | Labai dažnai (80–99%) | 4 ligose |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Labai dažnai (80–99%) | 6 ligose |
| IFNGR1interferon gamma receptor 1 | Labai dažnai (80–99%) | 1 ligoje |
| IL10interleukin 10 | Labai dažnai (80–99%) | 2 ligose |
| IL12Ainterleukin 12A | Labai dažnai (80–99%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Labai dažnai (80–99%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Labai dažnai (80–99%) | 1 ligoje |
| IL2RAinterleukin 2 receptor subunit alpha | Labai dažnai (80–99%) | 2 ligose |
| IL2RBinterleukin 2 receptor subunit beta | Labai dažnai (80–99%) | 2 ligose |
| IL6interleukin 6 | Labai dažnai (80–99%) | 1 ligoje |
| IRF4interferon regulatory factor 4 | Labai dažnai (80–99%) | 2 ligose |
| KLRC4killer cell lectin like receptor C4 | Labai dažnai (80–99%) | 1 ligoje |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Labai dažnai (80–99%) | 3 ligose |
| MIFmacrophage migration inhibitory factor | Labai dažnai (80–99%) | 1 ligoje |
| MMP14matrix metallopeptidase 14 | Labai dažnai (80–99%) | 1 ligoje |
| MMP2matrix metallopeptidase 2 | Labai dažnai (80–99%) | 1 ligoje |
Rodyti dar 133 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| NOD2nucleotide binding oligomerization domain containing 2 | Labai dažnai (80–99%) | 3 ligose |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Labai dažnai (80–99%) | 2 ligose |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Labai dažnai (80–99%) | 5 ligose |
| STAT4signal transducer and activator of transcription 4 | Labai dažnai (80–99%) | 5 ligose |
| TLR4toll like receptor 4 | Labai dažnai (80–99%) | 1 ligoje |
| TNFRSF11BTNF receptor superfamily member 11b | Labai dažnai (80–99%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Labai dažnai (80–99%) | 1 ligoje |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Dažnai (30–79%) | 1 ligoje |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Dažnai (30–79%) | 1 ligoje |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| BLNKB cell linker | Dažnai (30–79%) | 1 ligoje |
| BTKBruton tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| C1QBcomplement C1q B chain | Dažnai (30–79%) | 1 ligoje |
| C2orf69chromosome 2 open reading frame 69 | Dažnai (30–79%) | 1 ligoje |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| CAV1caveolin 1 | Dažnai (30–79%) | 1 ligoje |
| CCN2cellular communication network factor 2 | Dažnai (30–79%) | 1 ligoje |
| CCR6C-C motif chemokine receptor 6 | Dažnai (30–79%) | 1 ligoje |
| CD79ACD79a molecule | Dažnai (30–79%) | 1 ligoje |
| CD79BCD79b molecule | Dažnai (30–79%) | 1 ligoje |
| COL2A1collagen type II alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| CR2complement C3d receptor 2 | Dažnai (30–79%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Dažnai (30–79%) | 3 ligose |
| DNASE1deoxyribonuclease 1 | Dažnai (30–79%) | 2 ligose |
| DNASE1L3deoxyribonuclease 1L3 | Dažnai (30–79%) | 1 ligoje |
| ETS1ETS proto-oncogene 1, transcription factor | Dažnai (30–79%) | 1 ligoje |
| FCGR2BFc gamma receptor IIb | Dažnai (30–79%) | 2 ligose |
| FCGR3BFc gamma receptor IIIb | Dažnai (30–79%) | 1 ligoje |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Dažnai (30–79%) | 1 ligoje |
| HPGD15-hydroxyprostaglandin dehydrogenase | Dažnai (30–79%) | 3 ligose |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Dažnai (30–79%) | 1 ligoje |
| IGHMimmunoglobulin heavy constant mu | Dažnai (30–79%) | 1 ligoje |
| IGLL1immunoglobulin lambda like polypeptide 1 | Dažnai (30–79%) | 1 ligoje |
| IL12Binterleukin 12B | Dažnai (30–79%) | 1 ligoje |
| IL36RNinterleukin 36 receptor antagonist | Dažnai (30–79%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Dažnai (30–79%) | 2 ligose |
| IRF5interferon regulatory factor 5 | Dažnai (30–79%) | 2 ligose |
| ITGAMintegrin subunit alpha M | Dažnai (30–79%) | 1 ligoje |
| JAZF1JAZF zinc finger 1 | Dažnai (30–79%) | 1 ligoje |
| KIAA0319LKIAA0319 like | Dažnai (30–79%) | 1 ligoje |
| KNSTRNkinetochore localized astrin (SPAG5) binding protein | Dažnai (30–79%) | 2 ligose |
| LBRlamin B receptor | Dažnai (30–79%) | 1 ligoje |
| LMX1BLIM homeobox transcription factor 1 beta | Dažnai (30–79%) | 1 ligoje |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Dažnai (30–79%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Dažnai (30–79%) | 1 ligoje |
| MVKmevalonate kinase | Dažnai (30–79%) | 2 ligose |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Dažnai (30–79%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Dažnai (30–79%) | 1 ligoje |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Dažnai (30–79%) | 3 ligose |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| PRKCDprotein kinase C delta | Dažnai (30–79%) | 1 ligoje |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Dažnai (30–79%) | 2 ligose |
| PRTN3proteinase 3 | Dažnai (30–79%) | 1 ligoje |
| PXKPX domain containing serine/threonine kinase like | Dažnai (30–79%) | 1 ligoje |
| SHARPINSHANK associated RH domain interactor | Dažnai (30–79%) | 1 ligoje |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Dažnai (30–79%) | 1 ligoje |
| SPI1Spi-1 proto-oncogene | Dažnai (30–79%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Dažnai (30–79%) | 2 ligose |
| TCF3transcription factor 3 | Dažnai (30–79%) | 1 ligoje |
| TLR7toll like receptor 7 | Dažnai (30–79%) | 1 ligoje |
| TNFAIP3TNF alpha induced protein 3 | Dažnai (30–79%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Dažnai (30–79%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Dažnai (30–79%) | 1 ligoje |
| TNIP1TNFAIP3 interacting protein 1 | Dažnai (30–79%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Dažnai (30–79%) | 3 ligose |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Dažnai (30–79%) | 1 ligoje |
| ACP5acid phosphatase 5, tartrate resistant | Kartais (5–29%) | 1 ligoje |
| ADARadenosine deaminase RNA specific | Kartais (5–29%) | 1 ligoje |
| AGAaspartylglucosaminidase | Kartais (5–29%) | 1 ligoje |
| ARVCFARVCF delta catenin family member | Kartais (5–29%) | 1 ligoje |
| BMP6bone morphogenetic protein 6 | Kartais (5–29%) | 1 ligoje |
| BTNL2butyrophilin like 2 | Kartais (5–29%) | 1 ligoje |
| COMTcatechol-O-methyltransferase | Kartais (5–29%) | 1 ligoje |
| EPCAMepithelial cell adhesion molecule | Kartais (5–29%) | 2 ligose |
| EXT1exostosin glycosyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| EXT2exostosin glycosyltransferase 2 | Kartais (5–29%) | 1 ligoje |
| FOXP3forkhead box P3 | Kartais (5–29%) | 1 ligoje |
| GJB2gap junction protein beta 2 | Kartais (5–29%) | 1 ligoje |
| GJB6gap junction protein beta 6 | Kartais (5–29%) | 1 ligoje |
| GP1BBglycoprotein Ib platelet subunit beta | Kartais (5–29%) | 1 ligoje |
| HFEhomeostatic iron regulator | Kartais (5–29%) | 1 ligoje |
| HIRAhistone cell cycle regulator | Kartais (5–29%) | 1 ligoje |
| HNF1BHNF1 homeobox B | Kartais (5–29%) | 1 ligoje |
| IFIH1interferon induced with helicase C domain 1 | Kartais (5–29%) | 2 ligose |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Kartais (5–29%) | 1 ligoje |
| IGKCimmunoglobulin kappa constant | Kartais (5–29%) | 1 ligoje |
| JMJD1Cjumonji domain containing 1C | Kartais (5–29%) | 1 ligoje |
| LRBALPS responsive beige-like anchor protein | Kartais (5–29%) | 1 ligoje |
| LSM11LSM11, U7 small nuclear RNA associated | Kartais (5–29%) | 1 ligoje |
| PHEXphosphate regulating endopeptidase X-linked | Kartais (5–29%) | 1 ligoje |
| RNASEH2Aribonuclease H2 subunit A | Kartais (5–29%) | 1 ligoje |
| RNASEH2Bribonuclease H2 subunit B | Kartais (5–29%) | 1 ligoje |
| RNASEH2Cribonuclease H2 subunit C | Kartais (5–29%) | 1 ligoje |
| RNF168ring finger protein 168 | Kartais (5–29%) | 1 ligoje |
| RNU7-1RNA, U7 small nuclear 1 | Kartais (5–29%) | 1 ligoje |
| RREB1ras responsive element binding protein 1 | Kartais (5–29%) | 1 ligoje |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Kartais (5–29%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| SEC24CSEC24 homolog C, COPII component | Kartais (5–29%) | 1 ligoje |
| SYKspleen associated tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| TBX1T-box transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| TFtransferrin | Kartais (5–29%) | 1 ligoje |
| THSD4thrombospondin type 1 domain containing 4 | Kartais (5–29%) | 1 ligoje |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Kartais (5–29%) | 1 ligoje |
| VPS13Avacuolar protein sorting 13 homolog A | Kartais (5–29%) | 1 ligoje |
| WASWASP actin nucleation promoting factor | Kartais (5–29%) | 1 ligoje |
| XIAPX-linked inhibitor of apoptosis | Kartais (5–29%) | 1 ligoje |
| CASP10caspase 10 | Retai (1–4 %) | 1 ligoje |
| FASLGFas ligand | Retai (1–4 %) | 1 ligoje |
| FGF10fibroblast growth factor 10 | Retai (1–4 %) | 1 ligoje |
| FGFR2fibroblast growth factor receptor 2 | Retai (1–4 %) | 1 ligoje |
| FGFR3fibroblast growth factor receptor 3 | Retai (1–4 %) | 1 ligoje |
| KRT5keratin 5 | Retai (1–4 %) | 1 ligoje |
| MYH14myosin heavy chain 14 | Retai (1–4 %) | 1 ligoje |
| POFUT1protein O-fucosyltransferase 1 | Retai (1–4 %) | 1 ligoje |
| POGLUT1protein O-glucosyltransferase 1 | Retai (1–4 %) | 1 ligoje |
| PSENENpresenilin enhancer, gamma-secretase subunit | Retai (1–4 %) | 1 ligoje |
| ABCG2ATP binding cassette subfamily G member 2 (JR blood group) | Neužfiksuota | 1 ligoje |
| ABCG8ATP binding cassette subfamily G member 8 | Neužfiksuota | 1 ligoje |
| ADA2adenosine deaminase 2 | Neužfiksuota | 1 ligoje |
| FCGR2AFc gamma receptor IIa | Neužfiksuota | 1 ligoje |
| HJVhemojuvelin BMP co-receptor | Neužfiksuota | 1 ligoje |
| HLA-Cmajor histocompatibility complex, class I, C | Neužfiksuota | 1 ligoje |
| HOXD10homeobox D10 | Neužfiksuota | 1 ligoje |
| NLRP12NLR family pyrin domain containing 12 | Neužfiksuota | 1 ligoje |
| PRG4proteoglycan 4 | Neužfiksuota | 1 ligoje |
| PSMB4proteasome 20S subunit beta 4 | Neužfiksuota | 1 ligoje |
| RAG1recombination activating 1 | Neužfiksuota | 1 ligoje |
| RAG2recombination activating 2 | Neužfiksuota | 1 ligoje |
| TFR2transferrin receptor 2 | Neužfiksuota | 1 ligoje |
| UBA1ubiquitin like modifier activating enzyme 1 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.17-8666dff2.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites